All News about Replicel Life Sciences Inc
RepliCel Provides Corporate Update
November 28, 2022
Via ACCESSWIRE
RepliCel Announces Material Patent Milestones in Key Markets
August 04, 2022
Via ACCESSWIRE
RepliCel’s Manufacturing Inspected by Japan’s PMDA
July 28, 2022
Via AccessWire
RepliCel’s Manufacturing Inspected by Japan’s PMDA
July 28, 2022
Via ACCESSWIRE
Via AccessWire
RepliCel Announces Material Patent Milestones
January 10, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
RepliCel Closed Final Tranche of Strategic Investment Commitment
December 21, 2021
Via AccessWire
RepliCel Terminates License Agreement with Shiseido
December 21, 2021
Via AccessWire
Via AccessWire
RepliCel Announces Dermal Injector Update
October 27, 2021
Via AccessWire
RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
October 12, 2021
Via AccessWire
Topics
Economy
Exposures
Economy
RepliCel Adds Independent Director
June 15, 2021
Via AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RepliCel Launches Testing of Dermal Injector Units
May 25, 2021
Via AccessWire
Via AccessWire
RepliCel Announces Record Year in Patents Granted
May 05, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.